During the past decade, Aurora Cancer Care-Kenosha South conducted 139 clinical trials. In the 10-year time frame, 139 clinical trials started and 70 clinical trials were completed, i.e. on average, 50.4% percent of trials that started reached the finish line to date. In the past 5 years, 51 clinical trials started and 58 clinical trials were completed. i.e. 113.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Aurora Cancer Care-Kenosha South" #1 sponsor was "National Cancer Institute (NCI)" with 89 trials, followed by "SWOG Cancer Research Network" with 29 trials sponsored, "Alliance for Clinical Trials in Oncology" with 19 trials sponsored, "NRG Oncology" with 19 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 19 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Aurora Cancer Care-Kenosha South" #1 collaborator was "National Cancer Institute (NCI)" with 91 trials as a collaborator, "NRG Oncology" with 22 trials as a collaborator, "Canadian Cancer Trials Group" with 12 trials as a collaborator, "Cancer and Leukemia Group B" with 6 trials as a collaborator and "SWOG Cancer Research Network" with 6 trials as a collaborator. Other collaborators include 44 different institutions and companies that were collaborators in the rest 35 trials.

According to Clinical.Site data, the most researched conditions in "Aurora Cancer Care-Kenosha South" are "Recurrent Squamous Cell Lung Carcinoma" (10 trials), "Invasive Breast Carcinoma" (9 trials), "Recurrent Breast Carcinoma" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials) and "Recurrent Ovarian Carcinoma" (7 trials). Many other conditions were trialed in "Aurora Cancer Care-Kenosha South" in a lesser frequency.

Most popular intervention types in "Aurora Cancer Care-Kenosha South" are "Drug" (145 trials), "Other" (124 trials), "Biological" (71 trials), "Procedure" (46 trials) and "Radiation" (38 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (62 trials), "Quality-of-Life Assessment" (59 trials), "Questionnaire Administration" (36 trials), "Computed Tomography" (24 trials) and "Paclitaxel" (21 trials). Other intervention names were less common.

The vast majority of trials in "Aurora Cancer Care-Kenosha South" are 143 trials for "All" genders, 31 trials for "Female" genders and 9 trials for "Male" genders.

Currently, there are NaN active trials in "Aurora Cancer Care-Kenosha South". undefined are not yet recruiting, 47 are recruiting, 97 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in Aurora Cancer Care-Kenosha South, 6 suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Aurora Cancer Care-Kenosha South, 3 "Phase 1" clinical trials were conducted, 81 "Phase 2" clinical trials and 111 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 7 trials that are defined as “Not Applicable".